Clinical trial investigates potential Alzheimer’s disease drug in people with Down syndrome

June 6, 2017 -phase 2 clinical trial in young adults with Down syndrome of a drug being investigated for the treatment of Alzheimer’s disease supports further investigation of its potential. Results of the four-week trial of scyllo-inositol, also known as ELND005, have been published in the Journal of Alzheimer’s Disease. More...

June 6, 2017

2017 Mathematics, Statistics and Analytics brochure available

June 6, 2017 - IOS Press Mathematics, Statistics and Analytics brochure More...

June 6, 2017

2017 Neuroscience & Neurology brochure available

June 6, 2017 - IOS Press Neuroscience & Neurology brochure More...

June 6, 2017

Can Omega-3 Help Prevent Alzheimer’s Disease? Brain SPECT Imaging Shows Possible Link

Neuroimaging shows increased blood flow in regions of the brain associated with memory and learning for people with higher omega-3 levels, according to a new report in the Journal of Alzheimer’s Disease

May 22, 2017 - The incidence of Alzheimer’s disease (AD) is expected to triple in the coming decades and no cure has been found. Recently, interest in dietary approaches for prevention of cognitive decline has increased. In particular, the omega-3 fatty acids have shown anti-amyloid, anti-tau and anti-inflammatory actions in the brains of animals. In a new article published in the Journal of Alzheimer’s Disease, researchers have found that for patients with high omega-3 levels, blood flow in specific areas of the brain is increased. More...

May 22, 2017